All.Can: changing cancer care together

All.Can is an international initiative working to improve efficiency in cancer care by focusing on what matters to patients.

Context

With the growing prevalence of cancer and ongoing pressures on healthcare budgets, there is a challenge to find sustainable solutions and improve efficiency in cancer care.

Across European health systems, 20% of spending is estimated to be wasted on ineffective interventions. This is not just a threat to health system sustainability, but also an unnecessary burden on patients and families. Inefficiency in healthcare costs patients in terms of lost time, anxiety, impact on quality of life and financial burden. Ineffective interventions may also increase risk of harm, and ultimately lead to poorer outcomes.

Current approaches to cancer care may not be sufficient for tomorrow. We must find new ways to maximise resources, ensuring that the needs of the patient are always the focus. This means eliminating elements that bring little or no benefit to patients while prioritising interventions that confer meaningful benefits.

All.Can imagines a world in which patients are always at the heart of cancer care. For more information, visit the All.Can website.

What we’ve achieved

HPP acted as secretariat for All.Can from the initiative’s inception in late 2016 until its incorporation as a not-for-profit association in May 2020.

As secretariat, HPP provided operational support to All.Can’s international steering committee and members. Members come from all sectors relevant to cancer care, including patient organisations, policymakers, healthcare professionals, research and industry representatives. HPP also supported the national All.Can initiatives across Europe, Australia, Canada and South America.

HPP led the research and drafting of the inaugural All.Can policy report in January 2017, and its adaptation into a peer-reviewed paper published in the Journal of Cancer Policy. We also led several further All.Can publications and events, including posters at the European Society for Medical Oncology (ESMO) Congress, sessions at the European Health Forum Gastein in 2017 and 2018, and articles in The Parliament MagazineOpen Access GovernmentBrain Tumour magazine and EuroHealth.

In 2018, HPP worked closely with Quality Health to conduct the All.Can patient survey across 10 countries to gain patient insights on where inefficiency occurs across the cancer care pathway. The findings were published in July 2019, with coverage in numerous news and healthcare publications including an opinion piece in BMJ.

When All.Can International was formally incorporated as a not-for-profit association in Belgium, HPP handed over the secretariat function to Interel Association Management. HPP continues to partner with All.Can International on a range of research projects. Chief among these is the All.Can efficiency hub, which brings together examples of best practice in improving efficiency in cancer care from across the world. HPP is also currently leading on the development of a new All.Can policy paper, looking at the role of data in improving efficiency in cancer care.

Key partners and stakeholders

All.Can International’s membership includes representatives from patient organisations, policymakers, healthcare professionals, research and industry. For the current list of members, along with information on All.Can International’s governance structure and the make-up of the various national initiatives, please visit the All.Can website.

Project funding

For full details of All.Can International’s funding, please see the All.Can website.

 

Related